Improving the efficacy of antibody-based cancer therapies

@article{Carter2001ImprovingTE,
  title={Improving the efficacy of antibody-based cancer therapies},
  author={Paul H Carter},
  journal={Nature Reviews Cancer},
  year={2001},
  volume={1},
  pages={118-129}
}
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies. 
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS